Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 230,399,934 papers from all fields of science
Search
Sign In
Create Free Account
cyclophosphamide/prednisone/procarbazine/vincristine protocol
Known as:
Cyclophosphamide/Prednisone/Procarbazine/Vincristine
, COPP
, Cytoxan-Oncovin-Procarbazine-Prednisone Regimen
Expand
A derivative of the original MOPP regimen consisting of cyclophosphamide, vincristine, procarbazine and prednisone used as an initial treatment for…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
10 relations
Adult Hodgkin Lymphoma
Prednisone
Procarbazine Hydrochloride
Vincristine
Expand
Broader (4)
Antineoplastic Combined Chemotherapy Protocols
Cyclophosphamide
Procarbazine
cisplatin/cyclophosphamide/etoposide protocol
Narrower (1)
Cyclophosphamide/Mechlorethamine/Prednisone/Procarbazine/Vincristine protocol
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Development of nitric oxide sensor for asthma attack prevention
M. R. Vilar
,
J. El-Beghdadi
,
+4 authors
A. Rego
2006
Corpus ID: 55020942
2004
2004
Beacopp Chemotherapy for Advanced Hodgkin’s Disease: Results of Further Analyses of the HD9- and HD12- Trials of the German Hodgkin Study Group (GHSG).
V. Diehl
,
C. Brillant
,
+4 authors
B. Pfistner
2004
Corpus ID: 209285747
Background: The BEACOPP regimen has proved to be superior to the conventional drug combination COPP/ABVD in the HD9 trial. In the…
Expand
2004
2004
Heme oxygenase-1 protects human hepatocytes in vitro against warm and cold hypoxia.
Eda Tüzüner
,
Liegang Liu
,
+7 authors
A. Nussler
Journal of Hepatology
2004
Corpus ID: 23427131
2004
2004
Cyclohexyl-octahydro-pyrrolo[1,2-a]pyrazine-Based Inhibitors of Human N-Myristoyltransferase-1
K. French
,
Y. Zhuang
,
Randy S. Schrecengost
,
Jean E. Copper
,
Zuping Xia
,
Charles D Smith
Journal of Pharmacology and Experimental…
2004
Corpus ID: 2438428
N-Myristoyltransferase (NMT) is an emerging therapeutic target that catalyzes the attachment of myristate to the N terminus of an…
Expand
Highly Cited
2002
Highly Cited
2002
Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the…
M. Sieber
,
H. Tesch
,
+23 authors
V. Diehl
Journal of Clinical Oncology
2002
Corpus ID: 26029885
PURPOSE To investigate whether treatment results in intermediate-stage Hodgkin's lymphoma can be improved by rapid application of…
Expand
2000
2000
Thyroid toxicity of treatment for Hodgkin's disease
W. Bethge
,
D. Guggenberger
,
Michael Bamberg
,
L. Kanz
,
Carsten Bokemeyer
Annals of Hematology
2000
Corpus ID: 21511072
Abstract Thyroid disease, especially hypothyroidism, is one of the more frequently encountered late endocrine sequelae of…
Expand
1999
1999
Hodgkin's disease in Turkish children: clinical characteristics and treatment results of 210 patients.
M. Büyükpamukçu
,
L. Atahan
,
M. Çaǧlar
,
T. Kutluk
,
C. Akyüz
,
V. Hazar
Pediatric Hematology & Oncology
1999
Corpus ID: 33617439
Although Hodgkin's disease (HD) is one of the common malignancies in childhood, there is limited information from developing…
Expand
Highly Cited
1998
Highly Cited
1998
Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy…
Hans Tesch
,
Volker Diehl
,
+17 authors
M. Loeffler
Blood
1998
Corpus ID: 2433612
The BEACOPP (bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) regimen, a rearranged…
Expand
1997
1997
Role of heme-hemopexin in human T-lymphocyte proliferation.
A. Smith
,
J. Eskew
,
C. Borza
,
M. Pendrak
,
R. Hunt
Experimental Cell Research
1997
Corpus ID: 13174
Heme-hemopexin supports and stimulates proliferation of human acute T-lymphoblastic (MOLT-3) cells, suggesting the participation…
Expand
1988
1988
Combined modality therapy for tumor stage mycosis fungoides: results of a 10-year follow-up.
D. Hallahan
,
M. Griem
,
+4 authors
J. Baron
Journal of Clinical Oncology
1988
Corpus ID: 2658761
Twenty-one patients with tumor stage mycosis fungoides (MF) with or without lymph node (LN) involvement, were treated with total…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE